Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MJT.0000000000001162 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Temozolomide-Associated Organizing Pneumonia.
Am J Ther
January 2023
Department of Internal Medicine, University of South Dakota, Sanford School of Medicine, Vermillion, SD.
Temozolomide-associated bronchiolitis obliterans organizing pneumonia successfully treated with high-dose corticosteroid.
J Korean Med Sci
April 2012
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Temozolomide is an oral alkylating agent with clinical activity against glioblastoma multiforme (GM). It is generally well-tolerated and has few pulmonary side effects. We report a case of temozolomide-associated brochiolitis obliterans organizing pneumonia (BOOP) requiring very high-dose corticosteroid treatment.
View Article and Find Full Text PDFTemozolomide-associated organizing pneumonitis.
Mayo Clin Proc
June 2007
Division of Pulmonary and Critical Care Medicine, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!